Pharmato
Pharmato provides AI software for pharmaceutical research, literature analysis, clinical intelligence, and drug pipeline data management.
Seed ·
Amount not disclosed in a source on record.
Funding history ↓About Pharmato
Recent Funding lists Pharmato under Health and bio. Its latest known round is a Seed round (October 2026); no sourced amount is on record for it yet. Investors on record for it include Enbo Life Sciences. It was founded by Gao Fei and Ye Zhongkai.
Funding rounds
- Seed · amount undisclosed
EEnbo Life Sciences (lead)
Source: donews.com - Website created
Founders and team
GF
Gao Fei FounderYZ
Ye Zhongkai Founder
Investors
Similar Health and bio companies
HHexagon Bio$62M Series B+ · Oct 2026
HHeyVoli$500K Pre Seed · Oct 2026
VVitalls$1.5M Seed · Oct 2026WWarp Sciences$215M Series A · Oct 2026
PPAM2L Biotechnologies$29.97M Series A · Oct 2026
CCureBay$10.55M Series B+ · Oct 2026
Questions and sources
Pharmato: questions and answers
- Who invested in Pharmato?
- Investors on record for Pharmato: Enbo Life Sciences. Enbo Life Sciences led a round.
- Who founded Pharmato?
- Pharmato was founded by Gao Fei and Ye Zhongkai.
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/pharmato (get a free API key).